C78.7
Secondary malignant neoplasm of liver and intrahepatic bile duct
Clinical Classification Guidelines
Medical Intelligence & Overview
Secondary malignant neoplasm of the liver and intrahepatic bile duct, classified under ICD-10 code C78.7, refers to cancer that has spread (metastasized) to these liver regions from a primary tumor located elsewhere in the body. Unlike primary liver cancer, which originates in the liver itself, secondary cancers are the result of cancer cells traveling through the bloodstream or lymphatic system and establishing new tumors in the liver. The liver’s rich blood supply makes it a common site for metastases from cancers such as colorectal, pancreatic, breast, or lung cancers. Understanding this condition aids in diagnosing, planning treatment, and managing prognosis.
Causes & Symptoms
Clinical Causes: Metastatic spread from primary tumors in other organs, especially colorectal, pancreatic, breast, and lung cancers. Circulatory spread of malignant cells through the blood or lymphatic vessels. Advanced primary cancers that invade neighboring tissues and vessels, facilitating dissemination.
Key Symptoms: Abdominal pain or discomfort, often in the upper right area. Unexplained weight loss and fatigue. Loss of appetite. Swelling or a mass in the abdomen. Jaundice, which causes yellowing of the skin and the whites of the eyes. Nausea and vomiting. Potential changes in bowel movements, such as diarrhea or constipation.
Diagnostic & Treatment
Diagnosis Path: To confirm secondary malignant neoplasm of the liver and intrahepatic bile duct, healthcare providers typically utilize a combination of diagnostic tools, including:
Treatment Protocols: Treatment options focus on controlling the spread of cancer, alleviating symptoms, and improving quality of life. The specific approach depends on factors such as the primary tumor source, extent of metastasis, and the patient’s overall health.
Clinical Advice & FAQs
Billing Guidance
Is C78.7 a billable ICD-10 code?
Yes, C78.7 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report C78.7?
Clinical documentation must specify the nature of Secondary malignant neoplasm of liver and intrahepatic bile duct and any associated comorbidities for accurate reporting.
Cite this Clinical Reference